US equities |
NVDA $239.91 ▲+0.42% SPCX $172.59 ▲+0.88% MU $1,064.82 ▲+0.08% MRVL $289.40 ▲+6.69% AMD $654.38 ▲+3.58% INTC $114.64 ▼-1.33% AVGO $379.50 ▲+4.69% TSLA $379.97 ▲+0.33%
FinancialContent

Latest News about NASDAQ:EDIT

Recent news which mentions NASDAQ:EDIT

3 Pharma Stocks Primed for May Investment Opportunities
Tags :GTBIF NASDAQ:COLL NASDAQ:EDIT
From StockNews.com
EDIT Stock Earnings: Editas Medicine Misses EPS, Misses Revenue for Q1 2024
Tickers EDIT
Tags EDIT Earnings Reports NASDAQ:EDIT
From InvestorPlace
3 Pharma Stocks to Snatch up During Market Dips
Tags :OPTN NASDAQ:EDIT :SPRO
From StockNews.com
4 Genomics Stocks to Consider Buying After the Crash
Tags NASDAQ:EDIT NYSE:NVTA NASDAQ:NTLA
From StockNews.com
EDIT Stock Is Plunging 20%. Here’s the Gene-Editing News Dragging It Down.
Tickers EDIT
Tags NASDAQ:EDIT Market News EDIT
From InvestorPlace
Why You Need to Avoid These 3 Downgraded Stocks
Tags OTHER OTC:ESYJY NASDAQ:EDIT NASDAQ:VISL
From StockNews.com
Editas Stock Isn’t Worth Buying This Early Into Treatment Development
Tickers EDIT
Tags Market News NASDAQ:EDIT EDIT
From InvestorPlace